Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 17 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
Site visit: Silvercorp’s Flagship Ying Mining District continues to impress analysts
Disseminated on behalf of Silvercorp Metals Inc. (NYSE-A/TSX: SVM) and includes paid advertisement. Silvercorp management…
-
Bolivia’s Political Reset Opens a New Chapter for Mining, Representing Fresh Opportunities for Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG)
Disseminated on behalf of New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) and includes…
-
Datavault AI Inc. (NASDAQ: DVLT) CEO Featured in Interview Noting AI Growth, Challenges
CEO Nathaniel Bradley discussed the broader AI, cybersecurity landscape while offering insight into how rapidly…